Identification of Aberrant Pathways and Network Activities from High-throughput Data
Overview
Affiliations
Many complex diseases such as cancer are associated with changes in biological pathways and molecular networks rather than being caused by single gene alterations. A major challenge in the diagnosis and treatment of such diseases is to identify characteristic aberrancies in the biological pathways and molecular network activities and elucidate their relationship to the disease. This review presents recent progress in using high-throughput biological assays to decipher aberrant pathways and network activities. In particular, this review provides specific examples in which high-throughput data have been applied to identify relationships between diseases and aberrant pathways and network activities. The achievements in this field have been remarkable, but many challenges have yet to be addressed.
Qian F, Kong W, Wang S Bosn J Basic Med Sci. 2022; 22(5):751-771.
PMID: 35366391 PMC: 9519154. DOI: 10.17305/bjbms.2021.7019.
Characteristics of genomic mutations and signaling pathway alterations in thymic epithelial tumors.
Yang W, Chen S, Cheng X, Xu B, Zeng H, Zou J Ann Transl Med. 2022; 9(22):1659.
PMID: 34988168 PMC: 8667121. DOI: 10.21037/atm-21-5182.
Borisov N, Ilnytskyy Y, Byeon B, Kovalchuk O, Kovalchuk I Int J Mol Sci. 2021; 22(1).
PMID: 33396562 PMC: 7795809. DOI: 10.3390/ijms22010388.
Multi-omic Pathway and Network Analysis to Identify Biomarkers for Hepatocellular Carcinoma.
Barefoot M, Varghese R, Zhou Y, Di Poto C, Ferrarini A, Ressom H Annu Int Conf IEEE Eng Med Biol Soc. 2020; 2019:1350-1354.
PMID: 31946143 PMC: 6986237. DOI: 10.1109/EMBC.2019.8856576.
Network-Based Protein Biomarker Discovery Platforms.
Kim M, Hwang D Genomics Inform. 2016; 14(1):2-11.
PMID: 27103885 PMC: 4838525. DOI: 10.5808/GI.2016.14.1.2.